Literature DB >> 13011047

Agranulocytosis following administration of phenylbutazone (butazolidin).

J L STIFEL, J C BURNHEIMER.   

Abstract

Entities:  

Keywords:  ACTH/therapeutic use; AGRANULOCYTOSIS/etiology and pathogenesis; ANALGESICS/toxicity

Mesh:

Substances:

Year:  1953        PMID: 13011047     DOI: 10.1001/jama.1953.02940070021007

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN: 0002-9955


× No keyword cloud information.
  7 in total

1.  Multiple toxic effects of phenylbutazone; report of a fatal case.

Authors:  T N FRASER
Journal:  Br Med J       Date:  1955-05-28

2.  Toxic effects of phenylbutazone.

Authors:  J R NASSIM; T PILKINGTON
Journal:  Br Med J       Date:  1953-06-13

3.  Multiple visceral lesions due o phenylbutazone toxicity.

Authors:  J R NASSIM
Journal:  Br Med J       Date:  1954-10-30

4.  Phenylbutazone and renal function.

Authors:  B M JOHNSON; I M LARKIN
Journal:  Br Med J       Date:  1954-11-06

5.  Phenylbutazone: an evaluation of its use.

Authors:  W G SNOW
Journal:  Calif Med       Date:  1953-09

6.  HEMATOLOGICAL COMPLICATIONS OF PHENYLBUTAZONE THERAPY: REVIEW OF THE LITERATURE AND REPORT OF TWO CASES.

Authors:  D D MCCARTHY; T M CHALMERS
Journal:  Can Med Assoc J       Date:  1964-05-02       Impact factor: 8.262

7.  Clinical experience with phenylbutazone (Butazolidin).

Authors:  J B FRAIN; J E MORRIS
Journal:  Can Med Assoc J       Date:  1954-11       Impact factor: 8.262

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.